Review of 2022 PSOGI/RENAPE Consensus on HIPEC

作者：Shigeki Kusamura, Aditi Bhatt, Kurt Van der Speeten, Vahan Képénékian, Martin Hübner, Clarisse Eveno, Ignace H. J. T. de Hingh, Jean‐Baptiste Delhorme, Abdelkader Taïbi, Laurent Villeneuve, Réa Lo Dico, Brendan John Moran, Kim Govaerts, Oliver Zivanovic, Donal J. Brennan, Cédric Nadeau, Willemien J. van Driel, Naoual Bakrin, Pompiliu Piso, Victor J. Verwaal, Santiago González‐Moreno, Mohammad S. Alyami, Olivia A. Sgarbura, Beate Rau, Marcello Deraco, Olivier Gléhen · 发表于：Journal of Surgical Oncology · 年份：2024 · DOI：10.1002/jso.27885 · 被引用次数：22 · 研究领域：Intraperitoneal and Appendiceal Malignancies、Appendicitis Diagnosis and Management、Hernia repair and management

The 2022 PSOGI (Peritoneal Surface Oncology Group International) and RENAPE (French Network for Rare Peritoneal Malignancies) consensus on hyperthermic intraperitoneal chemotherapy (HIPEC) was a comprehensive effort aimed at standardizing treatment protocols for various peritoneal malignancies. This initiative is critical due to the wide range of technical variations in HIPEC procedures and the resulting need for standardization to ensure consistent and effective patient care and meaningful audit of multicenter data.